Trial Details
COMPLETEDBasic Information
| Clinical ID | c636 |
|---|---|
| Identifier | NCT06291948 |
| Trial Title | A Clinical Study With Adalimumab Biosimilar |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Pharmacokinetics|Safety Issues |
| Interventions | BIOLOGICAL: Humira® (adalimumab) AC Pen [Reference Product]|BIOLOGICAL: Adalimumab Richmond [Test Product] |
Participant Information
| Sponsor | Laboratorios Richmond S.A.C.I.F. |
|---|---|
| City | Buenos Aires |
| Country/Region | Argentina |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2022-08-01 |
|---|---|
| Primary Completion Date | 2023-01-10 |
| Completion Date | 2023-10-20 |